ロード中...
Improvements in Glycemic Control Achieved by Altering the t(max) Setting in the iLet(®) Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial
INTRODUCTION: We investigated the safety of, and glucose control by, the insulin-only configuration of the iLet(®) bionic pancreas delivering fast-acting insulin aspart (faster aspart), using the same insulin-dosing algorithm but different time to maximal serum drug concentration (t(max)) settings,...
保存先:
| 出版年: | Diabetes Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8266971/ https://ncbi.nlm.nih.gov/pubmed/34146238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01087-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|